Home LiteratureArticle Details
PMID: 19898493 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Direct cell reprogramming is a stochastic process amenable to acceleration.

Nature ·Vol. 462 ·No. 7273 ·2009-12-03 ·Pages 595-601

Hanna J, Saha K, Pando B, van Zon J, Lengner CJ, Creyghton MP, van Oudenaarden A, Jaenisch R

Abstract

Direct reprogramming of somatic cells into induced pluripotent stem (iPS) cells can be achieved by overexpression of Oct4, Sox2, Klf4 and c-Myc transcription factors, but only a minority of donor somatic cells can be reprogrammed to pluripotency. Here we demonstrate that reprogramming by these transcription factors is a continuous stochastic process where almost all mouse donor cells eventually give rise to iPS cells on continued growth and transcription factor expression. Additional inhibition of the p53/p21 pathway or overexpression of Lin28 increased the cell division rate and resulted in an accelerated kinetics of iPS cell formation that was directly proportional to the increase in cell proliferation. In contrast, Nanog overexpression accelerated reprogramming in a predominantly cell-division-rate-independent manner. Quantitative analyses define distinct cell-division-rate-dependent and -independent modes for accelerating the stochastic course of reprogramming, and suggest that the number of cell divisions is a key parameter driving epigenetic reprogramming to pluripotency.

MeSH Terms
Animals Cell Differentiation Cell Division Cell Line Cellular Reprogramming Gene Expression Regulation, Developmental Kruppel-Like Factor 4 Mice Mice, SCID Models, Biological Pluripotent Stem Cells/cytology,metabolism Time Factors Transcription Factors/genetics,metabolism
Chemicals
Klf4 protein, mouse Kruppel-Like Factor 4 Transcription Factors
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Hanna Jacob
The Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA. [email protected]
Saha Krishanu
Pando Bernardo
van Zon Jeroen
Lengner Christopher J
Creyghton Menno P
van Oudenaarden Alexander
Jaenisch Rudolf
References (46)
46 references, click to expand
  1. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells.
    Nat Genet. 2009 Sep;41(9):968-76 PMID: 19668214
  2. Elite and stochastic models for induced pluripotent stem cell generation.
    Nature. 2009 Jul 2;460(7251):49-52 PMID: 19571877
  3. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.
    Cell Stem Cell. 2008 Mar 6;2(3):230-40 PMID: 18371448
  4. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells.
    Nature. 2009 Aug 27;460(7259):1145-8 PMID: 19668190
  5. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.
    Nature. 2009 Aug 27;460(7259):1132-5 PMID: 19668191
  6. Variable reprogramming of the pluripotent stem cell marker Oct4 in mouse clones: distinct developmental potentials in different culture environments.
    Stem Cells. 2005 Sep;23(8):1089-104 PMID: 15955835
  7. Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features.
    Development. 2006 Mar;133(6):1193-201 PMID: 16501172
  8. Transgenic mice with defined combinations of drug-inducible reprogramming factors.
    Nat Biotechnol. 2009 Feb;27(2):169-71 PMID: 19151700
  9. Nature, nurture, or chance: stochastic gene expression and its consequences.
    Cell. 2008 Oct 17;135(2):216-26 PMID: 18957198
  10. Nanog is the gateway to the pluripotent ground state.
    Cell. 2009 Aug 21;138(4):722-37 PMID: 19703398
  11. Lin28 modulates cell growth and associates with a subset of cell cycle regulator mRNAs in mouse embryonic stem cells.
    RNA. 2009 Mar;15(3):357-61 PMID: 19147696
  12. Nanog safeguards pluripotency and mediates germline development.
    Nature. 2007 Dec 20;450(7173):1230-4 PMID: 18097409
  13. Induced pluripotent stem cell lines derived from human somatic cells.
    Science. 2007 Dec 21;318(5858):1917-20 PMID: 18029452
  14. Nanog promotes transfer of pluripotency after cell fusion.
    Nature. 2006 Jun 22;441(7096):997-1001 PMID: 16791199
  15. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene.
    Nat Cell Biol. 2005 Nov;7(11):1074-82 PMID: 16244670
  16. Generation of germline-competent induced pluripotent stem cells.
    Nature. 2007 Jul 19;448(7151):313-7 PMID: 17554338
  17. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity.
    Nature. 2009 Aug 27;460(7259):1149-53 PMID: 19668189
  18. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types.
    Nat Biotechnol. 2008 Aug;26(8):916-24 PMID: 18594521
  19. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.
    Cell. 2008 Feb 22;132(4):567-82 PMID: 18295576
  20. Role of the murine reprogramming factors in the induction of pluripotency.
    Cell. 2009 Jan 23;136(2):364-77 PMID: 19167336
  21. Oct4-induced pluripotency in adult neural stem cells.
    Cell. 2009 Feb 6;136(3):411-9 PMID: 19203577
  22. Stochasticity in gene expression: from theories to phenotypes.
    Nat Rev Genet. 2005 Jun;6(6):451-64 PMID: 15883588
  23. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells.
    Nature. 2009 Jul 2;460(7251):118-22 PMID: 19571885
  24. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds.
    Cell Stem Cell. 2008 Nov 6;3(5):568-74 PMID: 18983970
  25. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
    Cell. 2006 Aug 25;126(4):663-76 PMID: 16904174
  26. Cre-lox-regulated conditional RNA interference from transgenes.
    Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10380-5 PMID: 15240889
  27. Core transcriptional regulatory circuitry in human embryonic stem cells.
    Cell. 2005 Sep 23;122(6):947-56 PMID: 16153702
  28. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.
    Science. 2007 Dec 21;318(5858):1920-3 PMID: 18063756
  29. Linking the p53 tumour suppressor pathway to somatic cell reprogramming.
    Nature. 2009 Aug 27;460(7259):1140-4 PMID: 19668186
  30. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.
    Nature. 2007 Jul 19;448(7151):318-24 PMID: 17554336
  31. Senescence impairs successful reprogramming to pluripotent stem cells.
    Genes Dev. 2009 Sep 15;23(18):2134-9 PMID: 19696146
  32. Developmental reprogramming after chromosome transfer into mitotic mouse zygotes.
    Nature. 2007 Jun 7;447(7145):679-85 PMID: 17554301
  33. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.
    Nat Biotechnol. 2008 Jul;26(7):795-7 PMID: 18568017
  34. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells.
    Cell. 2003 May 30;113(5):631-42 PMID: 12787504
  35. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.
    Cell Stem Cell. 2008 Feb 7;2(2):151-9 PMID: 18371436
  36. The Ink4/Arf locus is a barrier for iPS cell reprogramming.
    Nature. 2009 Aug 27;460(7259):1136-9 PMID: 19668188
  37. Mediators of reprogramming: transcription factors and transitions through mitosis.
    Nat Rev Mol Cell Biol. 2008 Jul;9(7):505-16 PMID: 18568039
  38. Reprogramming cell fates: reconciling rarity with robustness.
    Bioessays. 2009 May;31(5):546-60 PMID: 19319911
  39. Metastable pluripotent states in NOD-mouse-derived ESCs.
    Cell Stem Cell. 2009 Jun 5;4(6):513-24 PMID: 19427283
  40. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.
    Cell. 2008 Apr 18;133(2):250-64 PMID: 18423197
  41. Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
    Cell. 2007 Nov 30;131(5):861-72 PMID: 18035408
  42. Dissecting direct reprogramming through integrative genomic analysis.
    Nature. 2008 Jul 3;454(7200):49-55 PMID: 18509334
  43. Molecular coupling of Xist regulation and pluripotency.
    Science. 2008 Sep 19;321(5896):1693-5 PMID: 18802003
  44. Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16Ink4a and Arf.
    Genes Dev. 2008 Nov 15;22(22):3115-20 PMID: 19056891
  45. Reprogramming of somatic cell identity.
    Cold Spring Harb Symp Quant Biol. 2008;73:147-55 PMID: 19022760
  46. RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development.
    Proc Natl Acad Sci U S A. 1993 May 15;90(10):4528-32 PMID: 8506294
Article Info
Journal
Nature
Abbr.
Nature
ISSN
1476-4687
Published
2009-12-03
Epub
2009-00-08
Pages
595-601
Language
English
Region
England
NLM ID
0410462
PMCID
PMC2789972
Subset
IM
Grants
PHS HHS · R01-HDO45022 · United States
NCI NIH HHS · R01 CA087869-09 · United States
NICHD NIH HHS · R01 HD045022-06 · United States
NCI NIH HHS · R37-CA084198 · United States
NCI NIH HHS · U54 CA143874 · United States
NCI NIH HHS · U54CA143874 · United States
NCI NIH HHS · R37 CA084198 · United States
NICHD NIH HHS · R01 HD045022 · United States
NCI NIH HHS · R01 CA087869 · United States
NCI NIH HHS · R37 CA084198-09 · United States
NCI NIH HHS · R01-CA087869 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]